Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,774,217
+$1,677,171 QoQ
Shares Held
416,483
+951.4% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 254 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. MNKD ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in MNKD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,774,217 | 416,483 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $97,046 | 39,611 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,745,198 | 484,162 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $930,449 | 173,268 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,386,349 | 905,441 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,914,508 | 380,618 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,528,153 | 237,660 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,786,780 | 1,237,962 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,474,379 | 474,019 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,126,811 | 910,996 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,694,192 | 1,014,888 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,019,316 | 973,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,598,673 | 884,195 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,472,757 | 847,014 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,087,483 | 2,862,900 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,587,826 | 2,779,232 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,287,366 | 2,437,629 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,040,864 | 1,369,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,883,768 | 1,346,400 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,112,990 | 1,175,400 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $5,457,075 | 1,392,111 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $172,550 | 55,128 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $375,624 | 199,800 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $507,850 | 290,200 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||